Converting oral to long-acting injectable antipsychotics: a guide for the perplexed
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
There has been increasing recognition that antipsychotic nonadherence is common across all stages of schizophrenia, starting from the first episode. Moreover, numerous meta-analyses of the existing literature indicate superiority of long-acting injectable (LAI) over oral antipsychotics when one adjusts for the greater illness severity and duration among patients in LAI antipsychotic trials. The increasing availability of LAI antipsychotic options has raised interest in converting patients from oral medication; however, the successful transition from oral to the comparable LAI antipsychotic requires an understanding of the current extent of antipsychotic exposure, the kinetics of the LAI preparation, and the expected plasma levels achieved by the LAI formulation. The purpose of this article is to provide, in a concise format, the essential information for converting patients to the LAI forms of haloperidol, fluphenazine, risperidone, paliperidone, olanzapine, and aripiprazole from the comparable oral medication, and how the use of plasma antipsychotic levels can be invaluable for this process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169
Tiihonen, J., Haukka, J., Taylor, M., Haddad, P. M., Patel, M. X., & Korhonen, P. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10081224 · Cited by 619
Subotnik, K. L., Casaus, L. R., Ventura, J., Luo, J. S., Hellemann, G. S., Gretchen-Doorly, D., Marder, S., & Nuechterlein, K. H. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0270 · Cited by 262 · cited 1×
“Although antipsychotic nonadherence rates in schizophrenia patients in all phases of the illness range from 44%–75%,(3) 2 factors contribute to underutilization of LAI preparations: (a) overestimation of the extent of oral medication adherence(8,9) and (b) incorrect assumptions regarding the unacceptability of LAI ant…”
BackgroundKishimoto, T., Hagi, K., Nitta, M., Leucht, S., Olfson, M., Kane, J. M., & Correll, C. U. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx090 · Cited by 186
Detke, H. C., Zhao, F., Garhyan, P., Carlson, J., & McDonnell, D. (2011) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32834093d1 · Cited by 185 · cited 3×
“Kinetic profiles of different 8-week loading strategies of olanzapine pamoate.(40) 24 J.”
BackgroundInfluentialThe effect of variable cigarette consumption on the interaction with clozapine and olanzapine
Haslemo, T., Eikeseth, P. H., Tanum, L., Molden, E., & Refsum, H. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-006-0209-9 · Cited by 178
Samtani, M. N., Vermeulen, A., & Stuyckens, K. (2009) · Clinical Pharmacokinetics · doi:10.2165/11316870-000000000-00000 · Cited by 170
Clinical Pharmacokinetics of the Depot Antipsychotics
Jann, M. W., Ereshefsky, L., & Saklad, S. R. (1985) · Clinical Pharmacokinetics · doi:10.2165/00003088-198510040-00003 · Cited by 125
McDonnell, D. P., Detke, H. C., Bergstrom, R. F., Kothare, P., Johnson, J., Stickelmeyer, M., Sanchez-Felix, M. V., Sorsaburu, S., & Mitchell, M. I. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-45 · Cited by 96 · cited 2×
“Severe sedation often requiring hospitalization occurred in approximately 2% of patients in the clinical trials with onset 30–300 minutes after injection.(41,42) While long-term inpatients may tolerate plasma olanzapine levels as high as 200 ng/ml after weeks of careful titration,(15) an analysis of post-injection del…”
BackgroundThe Pharmacokinetics of Long-Acting Antipsychotic Medications
Spanarello, S., & Ferla, T. (2014) · Current Clinical Pharmacology · doi:10.2174/15748847113089990051 · Cited by 70 · cited 4×
“Approved in February 2013, Abilify Maintena® is a lyophilized powder of aripiprazole monohydrate crystals with mean particle size of 1–10 μm (primarily 2–4 μm).(20) The particles are poorly soluble, resulting in slow and prolonged dissolution and absorption.”
BackgroundInfluential
Cited by
Schoretsanitis, G., Spina, E., Hiemke, C., & de Leon, J. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1549489 · Cited by 50
Correll, C. U., Sliwa, J. K., Najarian, D. M., & Saklad, S. R. (2019) · CNS Spectrums · doi:10.1017/s1092852918001098 · Cited by 27
Metadata
- Authors
- Meyer, J. M.
- Venue
- CNS Spectrums
- Publisher
- Cambridge University Press (CUP)
- Published
- 2017-12
- Volume
- 22
- Issue
- S1
- Pages
- 14-28
- ISSN
- 1092-8529 (ISSN-L)
- 2165-6509
- OpenAlex
- W2784903423
- Cited by
- 196
- References
- 13
- FWCI
- 34.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Converting oral to long-acting injectable antipsychotics: a guide for the perplexed. https://app.cochat.ai/papers/10.1017/s1092852917000840
- The paper
- Meyer, J. M. (2017). Converting oral to long-acting injectable antipsychotics: a guide for the perplexed. CNS Spectrums. https://doi.org/10.1017/s1092852917000840
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.